Clinical Trial

Personalized Risk Stratification Model of Follicular Lymphoma Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims at developping and validating an integrated clinico-molecular model for an accurate identification of FL patients who are progression free and progressed, respectively, at 24 months after treatment.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2018-02-12; most recent amendment 2025-11-14.
Status change: Recruiting → Active, Not Recruiting 2021-09-08
Status change: Not Yet Recruiting → Recruiting 2018-08-13
Trial Details
NCT Number NCT03436602
Lead Sponsor Oncology Institute of Southern Switzerland
Collaborators: Azienda Ospedaliero Universitaria Maggiore della Carita, Azienda USL Reggio Emilia - IRCCS, Institute of Pathology, Locarno, Ticino, Switzerland
Conditions Follicular Lymphoma
Enrollment 370 participants
Start Date 2018-03-01
Primary Completion 2021-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-18